Department of Bioengineering and Therapeutic Sciences

Research areas

From molecular discovery to therapeutic innovation, we combine bioengineering with computational science to develop personalized treatments. Our research integrates genetic analysis, advanced biomarker detection, and quantitative modeling to accelerate the development of precise, effective therapies. See all of our research areas.

  • Computational Biology and Systems Pharmacology

    Advancing drug discovery and treatment optimization through computational modeling and systems-level analysis of biological processes.

    Learn more about pharmacology

  • Drug Development & Regulatory Sciences

    Understanding how genetic variation impacts drug response to enable more precise and personalized therapeutic strategies.

    Learn more about drug sciences

  • Therapeutic Bioengineering

    Understanding how genetic variation impacts drug response to enable more precise and personalized therapeutic strategies.

    Learn more about bioengineering

  • Pharmacogenomics & Genomics

    Understanding how genetic variation impacts drug response to enable more precise and personalized therapeutic strategies.

    Learn more about pharmcogenomics

AI-Driven Drug Development

$30M

Leading a $30M initiative to accelerate drug development using artificial intelligence (AI).

Microbiome Discovery

14,000

Pioneering the analysis of over 14,000 biosynthetic gene clusters across 2,500 human-associated bacteria to discover new therapeutic compounds.

Leads in NIH Funding

46th year

In 2025, and for the 46th consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school.

News

More News